Fulcrum Therapeutics, Inc. FULC

New CRISPR/Cas9 patent issued to Carribou Bio $CRBU

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=11,111,506&OS=11,111,506&RS=11,111,506

$CRBU
Take a look at Caribou Biosciences.

Leader in CRISPR Gene editing. Cure to all diseases.

Founded by Nobel winner Jennifer Doudna and CEO Rachel Haurwitz.

Market cap 1.3 Billion.

They have 14,453,932 shares of Intellia (NTLA). Worth $2.5 Billion alone. Check out filings:

https://www.sec.gov/edgar/browse/?CIK=1619856&owner=exclude

They have about $500 Million in cash from recent IPO.

Listen to The Code Breaker by Walter Isaacson on Audible. https://www.audible.com/pd?asin=179711705X&source_code=ASSORAP0511160006

Check out patents:

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=0&f=S&l=50&d=PTXT&RS=AN%2FCaribou&Refine=Refine+Search&Query=AN%2FCaribou+AND+Biosciences

Working on cure for cancer.

https://www.cariboubio.com

This has potential for x 1000

Do your own due diligence.

Good luck

$FULC check out $CNDT, they just blew earnings out. They are in the transportation business, the infrastructure bill will make this fly! 4 billion annual revenue with only 1.3 billion market cap. Let’s get the apes on board ???